Bioxytran's total assets for Q were $159.01K, an increase of 23.69% from the previous quarter. BIXT total liabilities were $1.24M for the fiscal quarter, a 1.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.